Axinn partners Jeny Maier and Lisl Dunlop spoke at ACI's Life Sciences Antitrust Virtual Conference, on September 30.
Jeny participated in a panel entitled, "The Trajectory of A Perfect Antitrust Storm: Examining What the Convergence of Interests in Competition Policy and Law in the New Administration Means for the Life Sciences Industry."
Lisl participated in a panel entitled, "The End of the Mega Deal?: What the Global Life Sciences Industry Needs to Know About the Multilateral Pharmaceutical Merger Task Force and the Future of M&A Internationally."
Click here for more information.